Publication | Open Access
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
37
Citations
45
References
2021
Year
MiR-142-3p is a novel and potential negative prognostic CSF marker of MS and a promising tool for identifying personalised therapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1